Anika Therapeutics (ANIK) Goodwill & Intangibles (2010 - 2026)

Anika Therapeutics (ANIK) has reported Goodwill & Intangibles for 17 consecutive years, with $9.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles fell 59.97% year-over-year to $9.5 million in Q2 2026; TTM through Jun 2026 was $9.5 million, a 59.97% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 63.82% from the prior year.
• Goodwill & Intangibles was $9.5 million for Q2 2026 at Anika Therapeutics, down from $9.6 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $119.8 million in Q1 2022 and troughed at $9.1 million in Q1 2025.
• A 5-year average of $63.8 million and a median of $57.3 million in 2024 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles tumbled 84.09% in 2025 and rose 5.14% in 2026, its largest moves.
• Over 5 years, Goodwill & Intangibles stood at $119.5 million in 2022, then plunged by 77.06% to $27.4 million in 2023, then slipped by 1.63% to $27.0 million in 2024, then plunged by 63.82% to $9.8 million in 2025, then declined by 2.35% to $9.5 million in 2026.
• The last three Goodwill & Intangibles figures came in at $9.5 million (Q2 2026), $9.6 million (Q1 2026), and $9.8 million (Q4 2025), per Business Quant data.